- info@novaerus.ie
- +353 (1) 255 1536
To assess the performance of the installed Novaerus test devices.
Novaerus devices were installed in the admission room in the Paediatric Department and in the Clinic of Pulmonology/Tuberculosis and Pulmonary Diseases.
In the admission room in the Paediatric Department, an initial baseline test was conducted to assess the current microbiological purity of the air, which produced a result of 183.46 CFU/m3 of air. Once the Novaerus devices were turned on, running 24 hours a day, it reduced to 104.83 CFU/m3 of air when tested a week later, and then to 72 CFU/m3 of air when tested a month later.
In the Clinic of Pulmonology/Tuberculosis and Pulmonary Diseases, an initial baseline test was conducted to assess the current microbiological purity of the air, which produced a result of 236 CFU/m3 of air. Once the Novaerus devices were turned on, running 24 hours a day, it reduced to 192 CFU/m3 of air when tested a week later.
The results presented indicate that Novaerus devices effectively reduce the number of airborne pathogens, having a positive effect on the epidemiological safety of both patients and hospital staff.
About Us
Novaerus is on a mission to reduce indoor airborne pollutants that lead to infection, allergies, asthma, and odour.
The patented plasma NanoStrike technology used in Novaerus portable devices was invented in Ireland in 2006.
Novaerus Devices
Stay Connected to Novaerus
To keep up to date with all developments and for the latest research and scientifically proven results please follow us on LinkedIn, Facebook and Youtube.
